Q32 Bio (QTTB) Interest Coverage Ratio (2017 - 2026)
Q32 Bio's (QTTB) quarterly Interest Coverage Ratio came in at 0.92 in Q1 2026, up 91.51% year-on-year from 0.48 in Q1 2025, and down 100.4% quarter-over-quarter from 229.4 in Q4 2025.
Q32 Bio (QTTB) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
Q32 Bio's Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 0.92 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 91.51% year-over-year to 0.92 in Q1 2026; TTM through Mar 2026 was 2.56, a 104.53% increase from a year earlier, with the FY2025 full-year figure at 2.39, up 487.02% from the prior year.
- Interest Coverage Ratio fell to 0.92 in Q1 2026 per QTTB's latest filing, from 229.4 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 229.4 in Q4 2025 and bottomed at 36.32 in Q4 2024.
- The 5-year median for Interest Coverage Ratio is 1.4 (2024), against an average of 5.77.
- Across the five-year window, Interest Coverage Ratio sank 4663.54% in 2023 and jumped 731.68% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 0.19 in 2022, then plunged by 3260.47% to 6.45 in 2023, then sank by 462.83% to 36.32 in 2024, then soared by 731.68% to 229.4 in 2025, then tumbled by 100.4% to 0.92 in 2026.
- Per Business Quant, the three latest QTTB Interest Coverage Ratio figures stand at 0.92 (Q1 2026), 229.4 (Q4 2025), and 6.74 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Q32 Bio | 225.00 Mn | 174.25 Mn | - | -0.92 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.92 |
| Dec 31, 2025 | 229.40 |
| Sep 30, 2025 | -6.74 |
| Jun 30, 2025 | -1.21 |
| Mar 31, 2025 | -10.88 |
| Dec 31, 2024 | -36.32 |
| Sep 30, 2024 | -0.30 |
| Jun 30, 2024 | -1.49 |
| Mar 31, 2024 | -1.40 |
| Dec 31, 2023 | -6.45 |
| Sep 30, 2023 | -15.98 |
| Jun 30, 2023 | -28.87 |
| Mar 31, 2023 | -18.43 |
| Dec 31, 2022 | -0.19 |
| Sep 30, 2022 | -0.71 |
| Jun 30, 2022 | -0.61 |
| Mar 31, 2022 | -0.79 |
| Dec 31, 2021 | -0.21 |
| Sep 30, 2021 | -1.77 |
| Jun 30, 2021 | -1.67 |